Pictet Asset Management Holding SA »

Allogene Therapeutics shares owned by Pictet Asset Management Holding SA

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Pictet Asset Management Holding SA from 13F filings

Historical chart of Pictet Asset Management Holding SA investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Pictet Asset Management Holding SA consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Pictet Asset Management Holding SA

Quarter filed Position value Share count Share price at filing
2024-03-31 $47k 11k 4.47

More positions owned by Pictet Asset Management Holding SA

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Thermo Fisher Scientific (TMO)
Apple (AAPL)
Amazon (AMZN)
Republic Services (RSG)
Alphabet Cap Stk Cl C (GOOG)
Nxp Semiconductors N V (NXPI)
Meta Platforms Cl A (META)
Waste Connections (WCN)
Synopsys (SNPS)
Applied Materials (AMAT)
Waste Management (WM)
Alphabet Cap Stk Cl A (GOOGL)
Xylem (XYL)

View all positions for Pictet Asset Management Holding SA

Top funds holding Allogene Therapeutics

FMR
Tpg Gp A
BlackRock
Vanguard Group
PRIMECAP Management Company
Jpmorgan Chase & Co
T. Rowe Price Associates
Boxer Capital
Citadel Advisors
Frazier Life Sciences Management
Woodline Partners
Geode Capital Management
Morgan Stanley
Dimensional Fund Advisors
Two Sigma Investments

View all funds holding Allogene Therapeutics